

Okinawa's recent election results may grant Tokyo greater military freedom in the region. Discover how...

Healthcare CIOs prioritize Epic modernization to balance uptime, performance, and cyber recovery amid rising cyberattack...

Hospital ransomware cost estimates reveal shutdowns can drain up to $1.9 million per day, forcing...
Read our latest Mold Alerts articles.

Lil Durk cleared of murder charges in federal trial, acquitted of all charges related to...

Government scientists use AI research assistants to analyze surging medical data, accelerating discoveries and improving...

The AI Bill of Materials lets healthcare leaders document data, models, and licensing to meet...

Digital health funding hits $7.4 billion in H1 2026, driving rapid growth for U.S. medtech startups and attracting venture capital despite tighter recipient poo




Digital health funding hits $7.4 billion in H1 2026, driving rapid growth for U.S. medtech startups and attracting venture capital...
Intuitive links its Q2 slowdown in da Vinci surgical robot procedures to the end of ACA premium subsidies, impacting patient...
Zimmer Biomet appoints Chintan Desai as new president of Asia Pacific region, leading medtech operations.
Abbott invests in advanced cancer testing to detect disease earlier and personalize treatments with innovative diagnostics.
Sarah Romano named SS Innovations CFO, bringing finance experience to the role, as the company's new chief financial officer.
HistoSonics gains approval for its tissue treatment system to destroy tumors with sound waves, initially for liver tumors, using histotripsy...
Edwards settlement sees the medical device maker pay a $10 million FTC penalty after sidestepping antitrust review in its JC...
J&J wins FDA approval for a dual-energy ablation catheter treating atrial fibrillation, combining radiofrequency and pulsed field energy for enhanced...
Physicians struggle to use wearable data from patients due to reimbursement and workflow barriers, limiting its potential in everyday clinical...
Penumbra tests new stroke treatment device in clinical trial for M2 occlusions, aiming to improve outcomes for stroke patients.